论文部分内容阅读
回顾分析了术中放疗与健择化疗 ,配合术后放疗 ,治疗不能手术切除的18例晚期胰腺癌。提示术中放疗配合健择新药化疗 ,明显提高中位生存期 ,在治疗晚期胰腺癌中有较好的临床价值。
Retrospective analysis of intraoperative radiotherapy and gemcitabine chemotherapy combined with postoperative radiotherapy for 18 cases of advanced pancreatic cancer that could not be surgically resected. It is suggested that intraoperative radiotherapy combined with gemcitabine chemotherapy significantly improves the median survival time and has a good clinical value in the treatment of advanced pancreatic cancer.